5-HT2C receptor agonists attenuate pain-related behaviour in a rat model of trigeminal neuropathic pain

European Journal of Pain

Volumn 14, Issue 10, 2010, Pages 999-1006

  Nakai, Kunihiro ^a   Nakae, Aya ^b   Oba, Sosuke ^a   Mashimo, Takashi ^b   Ueda, Koichi ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

5 HT2C receptor; Infraorbital nerve; Nerve injury; Orofacial neuropathic pain; Trigeminal nerve

Indexed keywords

2 (6 CHLORO 5 FLUORO 1 INDOLYL) 1 METHYLETHYLAMINE; 6 CHLORO 2 (1 PIPERAZINYL)PYRAZINE; 8 [5 [2,4 DIMETHOXY 5 (4 TRIFLUOROMETHYLPHENYLSULFONAMIDO)PHENYL] 5 OXOPENTYL] 1,3,8 TRIAZASPIRO[4.5]DECANE 2,4 DIONE; 8,9 DICHLORO 2,3,4,4A TETRAHYDRO 1H PYRAZINO[1,2 A]QUINOXALIN 5(6H) ONE; SEROTONIN 2C RECEPTOR;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DOSE RESPONSE; DRUG SELECTIVITY; INFRAORBITAL NERVE; MALE; NERVE LIGATION; NEUROPATHIC PAIN; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; SKIN NERVE; TRIGEMINUS NEURALGIA;

ANIMALS; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHYLAMINES; INDOLES; INJECTIONS, SPINAL; MALE; NEURALGIA; PAIN MEASUREMENT; PAIN THRESHOLD; PHYSICAL STIMULATION; PYRAZINES; QUINOXALINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2C; SEROTONIN ANTAGONISTS; SEROTONIN RECEPTOR AGONISTS; SPIRO COMPOUNDS; SULFONAMIDES; TRIGEMINAL NEURALGIA;

EID: 78349304985     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1016/j.ejpain.2010.04.008     Document Type: Article

References (71)

1. W.M. Abi-Saab, M. Bubser, R.H. Roth, and A.Y. Deutch 5-HT2 receptor regulation of extracellular GABA levels in the prefrontal cortex Neuropsychophamacology 20 1999 92 96
2. A.A. Alhaider, S.Z. Lei, and G.L. Wilcox Spinal 5-HT3 receptor-mediated antinociception: possible release of GABA J Neurosci 11 1991 1881 1888
3. D. Ahn, Y. Kim, and J. Park Central NO is involved in the antinociceptive action of intracisternal antidepressants in freely moving rats Neurosci Lett 243 1998 105 108 (Pubitemid 28109422)
4. A.J. Beitz The nuclei of origin of brainstem serotonergic projections to the rodent spinal trigeminal nucleus Neurosci Lett 32 1982 223 228
5. G. Bennett, and Y.K. Xie A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man Pain 33 1988 87 107
6. R. Benoleil, E. Eliav, and M. Tal No sympathetic nerve sprouting in rat trigeminal ganglion following painful and non-painful infraorbital nerve neuropathy Neurosci Lett 297 2001 151 154
7. D.W. Bonhaus, K.K. Weihardt, M. Taylor, A. Desouza, P.M. Mcneeley, and K. Szczepanski RS-102221: a novel high affinity and selective, 5-HT2C receptor antagonist Neuropharmacology 36 1997 621 629
8. L.J. Boothman, K.A. Allers, K. Rasmussen, and T. Sharp Evidence that central 5-HT2A and 5-HT2B/C receptors regulate 5-HT cell firing in the dorsal raphe nucleus of the anaesthetized rat Brit J Pharmacol 139 5 2003 998 1004
9. L. Boothman, J. Raley, F. Denk, E. Hirani, and T. Sharp In vivo evidence that 5-HT2C receptors inhibit 5-HT neuronal activity via a GABAergic mechanism Brit J Pharmacol 149 2006 861 869
10. C. Burns, H. Chu, S.M. Ruester, L.K. Hutchinson, H. Canton, and E. Sanders-Bush Regulation of serotonin-2C receptor G-protein coupling by RNA editing Nature 387 1997 303 308
11. B.T. Chen, and M.E. Rice Synaptic regulation of somatodendritic dopamine release by glutamate and GABA differs between substantia nigra and ventral tegmental area J Neurochem 81 2002 158 169
12. D. Christensen, M. Gautron, D. Guibaud, and V. Kayser Combined systemic administration the glycine/NMDA receptor antagonist, (+)-HA966, and morphine attenuates pain-related behaviour in a rat model of trigeminal neuropathic pain Pain 83 1999 433 440
13. D. Christensen, M. Gautron, D. Guibaud, and V. Kayser Effect of gabapentin and lamotrigine on mechanical allodynia-like behaviour in a rat model of trigeminal neuropathic pain Pain 93 2001 147 153
14. A. Clatworthy, J. Williams, and S. Barasi Intrathecal 5-hydroxytryptamine and electrical stimulation of the nucleus raphe magnus in rats both reduce the antinociceptive potency of intrathecally administered noradrenaline Brain Res 455 1988 300 306
15. U. Coffeen, A. Lopez-Avila, J.M. Ortega-Legaspi, R. Del Angel, F.J. Lopez-munoz, and F. Pellicer Dopamine receptors in the anterior insular cortex modulate long term nociception in rat Eur J Pain 12 2008 535 543
16. F.C. Colpaert, J.P. Tarayre, W. Koek, P.J. Pauwels, L. Bardin, and X.-J. Xu Large-amplitude 5-HT1A receptor activation: a new mechanism of profound, central analgesia Neuropharmacology 43 2002 945 958
17. P.J. Conn, and E. Sander-Bush Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT-2 and 5-HT-1C) receptors J Pharmacol Exp Ther 424 1987 552 557
18. K. Deseure, W. Koek, F.C. Colpaert, and H. Adriaensen The 5-HT1A receptor agonist F 13640 attenuates mechanical allodynia in a rat model of trigeminal neuropathic pain Eur J Pharmacol 456 2002 51 57
19. H.L. Fields, M.M. Heinricher, and P. Mason Neurotransmitters in nociceptive modulatory control Annu Rev Neurosci 14 1991 219 245
20. K.B. Fink, and M Göthert 5-HT receptor regulation of neurotransmitter release Pharmacol Rev 59 4 2007 360 417
21. M.I. Fonseca, Y.G. Ni, D.D. Dunning, and R. Miledi Distribution of serotonin 2A, 2C, and 3 receptor mRNA in spinal cord and medulla oblongata Mol Brain Res 89 2001 11 19
22. C. Ghelardini, N. Galeotti, F. Casamenti, P. Malmberg-Aiello, G. Pepeu, and F. Gualtieri Central cholinergic antinociception induced by 5-HT4 agonists: BIMU 1 and BIMU 8 Life Sci 58 1996 2297 2309
23. M. Giorgetti, G. Hostenpiller, W. Froestl, and M.E. Wolf In vivo modulation of ventral tegmental area dopamine and glutamate efflux by local GABAB receptors is altered after repeated amphetamine treatment Neuroscience 109 3 2002 585 595
24. M. Giorgetti, and L.H. Tecott Contribution of 5-HT2C receptors to multiple actions of central serotonin systems Eur J Pharmacol 488 2004 1 9
25. A.J. Grottick, P.J. Fletcher, and G.A. Higgins Studies to Investigate the Role of 5-HT2C receptors on cocaine- and food-maintained behavior J Pharmacol Exp Ther 295 3 2000 1183 1191
26. K. Herrick-Davis, E. Grinde, and C.M. Niswender Serotonin 5-HT2C receptor RNA editing alters receptor basal activity: implications for serotonergic signal transduction J Neurochem 73 1999 1711 1717
27. R.W. Invernizzi, M. Pierucci, E. Calcagno, G. Di Giovanni, V. Di Matteo, and A. Benigno Selective activation of 5-HT(2C) receptors stimulates GABA-ergic function in the rat substantia nigra pars reticulata: a combined in vivo electrophysiological and neurochemical study Neuroscience 144 4 2007 1523 1535
28. J.J. Idänpään-Heikkilä, and G. Guilbaud Pharmacological studies on a rat model of trigeminal neuropathic pain: baclofen, but not carbamazepine, morphine or tricyclic antidepressants, attenuates the allodynia-like behaviour Pain 79 1999 281 290
29. C.Y. Jeong, J.I. Choi, and M.H. Yoon Roles of serotonin receptor subtypes for the antinociception of 5-HT in the spinal cord of rats Eur J Pharmacol 502 2004 205 211
30. P. Jungell, and C. Lindquist Paraesthsia of the infraorbital nerve following fracture of the zygomatic complex Int J Oral Max Surg 16 1987 363 367
31. V. Kayser, B. Aubel, M. Hamon, and S. Bourgoin The antimigraine 5-HT1B/1D receptor agonists, sumatoriptan, zolmitriptan and dihydroergotamine, attenuate pain-related behaviour in a rat model of trigeminal neuropathic pain Brit J Pharmacol 137 2002 1287 1297
32. G.N. Kryzhanovski, V.K. Reshnyak, V.G. Dolgikh, M.P. Gorizontova, and T.V. Speranskaya Trigeminal neuralgia of neuropathic origin Bull Exp Biol Med 112 1992 1059 1062 [English Version]
33. G.N. Kryzhanovski, V.G. Dolgikh, M.P. Gorizontova, and I.V. Mironova Formation of a pathological system in rats with neuropathic trigeminal neuralgia Bull Exp Biol Med 115 1993 623 625 [English Version]
34. A. Latrémolire, A. Mauborgne, J. Masson, S. Bourgoin, V. Kayser, and M. Hamon Differential implication of proinflammatory cytokine interleukin-6 in the development of cephalic versus extracephalic neuropathic pain in rats J Neurosci 28 2008 8489 8501
35. G.M. Leggio, A. Cathala, D. Moison, K.A. Cunningham, P.V. Piazza, and U. Spampinato Serotonin2C receptors in the medial prefrontal cortex facilitate cocaine-induced dopamine release in the rat nucleus accumbens Neurophamacology 56 2 2009 507 513
36. A. Lopez-Avila, U. Coffeen, J.M. Ortega-Legasipi, R. Del Angel, and F. Pellicer Dopamine and NMDA systems modulate long-term nociception in the rat anterior cingulated cortex Pain 111 2004 136 143
37. J.M. Marchena, B.L. Padwa, and L.B. Kaban Sensory abnormalities associated with mandibular fractures: incidence and natural history J Oral Max Surg 56 1998 822 825
38. J.R. Martin, M. Bös, F. Jenck, J.L. Moreau, V. Mutel, and A.J. Sleight 5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential J Paramacol Exp Ther 286 1998 913 924
39. V. Matteo, A. Blasi, C. Giulio, and E. Esposito Role of 5-HT2C receptors in the control of central dopamine function Trends Pharmacol Sci 22 5 2001 229 232
40. D. Mayer, T. Wolfe, H. Akil, B. Carder, and J. Liebeskins Analgesia from electrical stimulation in the brainstem of the rat Science 174 1971 1351 1354
41. S.M. Molineaux, T.M. Jessell, R. Axel, and D. Julius 5-HT1C receptor is a prominent serotonin receptor subtype in the central nervous system Proc Natl Acad Sci USA 86 1989 6793 9797
42. K.A. Moore, T. Kohno, L.A. Karchewski, J. Scholz, H. Baba, and C.J. Woolf Partial peripheral nerve injury promotes a selective loss of gabaergic inhibition in the superficial dorsal horn of the spinal cord J Neurosci 22 2002 6724 6731
43. M. Naguib, and T.L. Yaksh Antinociceptive effects of spinal cholinesterase inhibition and isobolographic analysis of the interaction with μ and α2 receptor systems Anesthesiology 80 1994 1338 1348
44. A. Nakae, K. Nakai, T. Tanaka, M. Takashina, S. Hagihira, and M. Shibata Serotonin 2C receptor mRNA editing in neuropathic pain model Neurosci Res 60 2008 228 231
45. A. Nakae, K. Nakai, T. Tanaka, S. Hagihira, M. Shibata, and K. Ueda The role of RNA editing of the serotonin 2C receptor in rat model of oro-facial neuropathic pain Eur J Neurosci 27 2008 2373 2379
46. C.M. Niswender, K. Herrick-Davis, C.E. Dilley, H.Y. Meltzer, J.C. Overholser, and C.A. Stockmeier RNA editing of the human serotonin HTR2C receptor: alterations in suicide and implications for serotonergic pharmacotherapy Neuropsychophamacology 24 2001 478 491
47. H. Obata, N. Ito, M. Sasaki, S. Saito, and F. Goto Possible involvement of spinal noradrenergic mechanism in the antiallodynic effect of intrathecally administered 5-HT2C receptor agonists in the rat with peripheral nerve injury Eur J Phamacol 567 2007 89 94
48. H. Obata, S. Saito, S. Sakurazawa, M. Sasaki, T. Usui, and F. Goto Antiallodynic effects of intrathecally admimistered 5-HT2C receptor agonists in rats with nerve injury Pain 108 2004 163 169
49. H. Obata, S. Saito, M. Sasaki, and F. Goto Possible involvement of a muscarinic receptor in the anti-allodynic action of a 5-HT2 receptor agonist in rats with nerve ligation injury Brain Res 932 2002 124 128
50. Z.G. Piao, I.H. Cho, C.K. Park, J.P. Hong, S.Y. Choi, and S.J. Lee Activation of glia and microglia p38 MAPK in medullary dorsal horn contributes to tactile hypersensivity following trigeminal sensory nerve injury Pain 121 2006 219 231
51. M. Pompeiano, J.M. Palacios, and G. Mengod Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors Mol Brain Res 23 1994 163 178
52. P. Queree, S. Peters, and T. Sharp Further pharmacological characterization of 5-HT2C receptor agonist-induced inhibition of 5-HT neuronal activity in the dorsal raphe nucleus in vivo Brit J Pharamacol 158 2009 1477 1485
53. G. Renzi, A. Carboni, M. Perugini, F. Giovannetti, and R. Becelli Posttraumatic trigeminal nerve impairment: a prospective analysis of recovery patterns in a series of 103 consecutive facial fractures J Oral Max Surg 62 2004 1341 1346
54. S. Rosenzweig-Lipson, J. Zhang, H. Mazandarani, B.J. Harrison, A. Sabb, and J. Sabalski Antiobesity-like effects of the 5-HT2C receptor agonist WAY-161503 Brain Res 1073-1074 2006 240 251
55. M. Sasaki, H. Obata, S. Saito, and F. Goto Antinociception with intrathecal alpha-methyl-5-hydroxytryptamine, a 5-hydroxytryptamine 2A/2C receptor agonist, in two rat models of sustained pain Anesth Analg 96 2003 1072 1078
56. J. Sawynok, and A. Reid Noradrenergic mediation of spinal antinociception by 5-hydroxytryptamine: characterization of receptor subtypes Eur J Pharmacol 223 1992 49 56
57. J. Sawynok, and A. Reid Interactions of descending serotonergic systems with other neurotransmitters in the modulation of nociception Behav Brain Res 73 1996 63 68
58. S. Schultze-Mosgau, M. Erbe, D. Rudolph, R. Ott, and F.W. Neukam Prospective study on post-traumatic and postoperative sensory disturbances of the inferior alveolar nerve and infraorbital nerve in mandibular and midfacial fractures J Craniomax Surg 27 1999 86 93
59. T. Sharp, L. Boothman, J. Raley, and P. Queree Important messages in the 'post': recent discoveries in 5-HT neurone feedback control Trends Pharmacol Sci 28 12 2007 629 636
60. S. Souvoravong, M.N. Nakashima, M. Wada, and K. Nakashima Decrease in serotonin concentration in raphe magnus nucleus and attenuation of morphine analgesia in two mice of neuropathic pain Eur J Phamacol 484 2004 217 223
61. W.H. Sweet Deafferentation pain after posterior rhizotomy, trauma to a limb, and herpes zoster Neurosurgery 15 1984 928 932
62. M. Swerdlow Anticonvulsivant drugs and chronic pain Clin Neurophamacol 7 1984 51 82
63. C. Vogel, R. Mossner, M. Gerlach, T. Heinemann, D. Murphy, and P. Riederer Absence of thermal hyperalgesia in serotonin transporter-deficient mice J Neurosci 23 2003 708 715
64. B.P. Vos, A.M. Strassman, and R.J. Maciewicz Behavioral evidence of trigeminal neuropathic pain following chronic constriction injury to the rat's infraorbital nerve J Neurosci 14 1994 2708 2723
65. B.P. Vos, and A.M. Strassman Fos expression in the medullary dorsal horn of the rat after chronic constriction injury to the infraorbital nerve J Comp Neurol 357 1995 362 375
66. B.H.C. Westerink, H.F. Kwint, and J.B. de Vries The pharmacology of mesolimbic dopamine neurons: A dual-probe microdialysis study in the ventral tegmental area and nucleus accumbens of the rat brain J Neurosci 16 8 1996 2605 2611
67. T. Yaksh, and T. Rudy Chronic catheterization of spinal subarachnoid space Physiol Behav 17 1976 1031 1036
68. T.L. Yaksh, J.W. Pogrel, Y.W. Lee, and S.R. Chaplan Reversal of nerve ligation-induced allodynia by spinal alpha-2 adrenoceptor agonists J Pharmacol Exp Ther 272 1995 207 214
69. T.L. Yaksh, R. Dirksen, and G.J. Harty Antinociceptive effects of intrathecally injected cholinomimetic drugs in the rat and cat Eur J Pharmacol 117 1985 81 88
70. F. Zemlman, S. Corrigan, and D. Pfaff Noradrenergic and serotonergic mediation of spinal analgesia mechanisms Eur J Pharmacol 61 1980 111 124
71. M. Zimmermann Ethical guidelines for investigations of experimental pain in conscious animals Pain 16 1983 109 110